EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY 4.0

Patterns of menopausal hormone therapy dispensing over 15 years—A Swedish register‐based cohort study

Rebecca Götze Eriksson iD, Fanny Söderquist, Ge Bai, Per Wikman, Diego Hernan Giunta, Inger Sundström Poromaa, Evangelia Elenis iD, Angelica Lindén Hirschberg, Alkistis Skalkidou, Stavros I Iliadis

Acta Obstetricia et Gynecologica Scandinavica · 2026

DOI: 10.1111/aogs.70225 ↗

At a glance

Kohortenstudie in Acta Obstetricia et Gynecologica Scandinavica, 2026. Written by Rebecca Götze Eriksson and 9 co-authors. Institution: Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. Major MEDLINE topics: Estrogen Replacement Therapy, Menopause, Practice Patterns, Physicians', Hormone Replacement Therapy. Cited 3 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: Svenska sällskapet för medicinsk forskning, Vetenskapsrådet, Cancerfonden.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Menopausal hormone therapy (MHT) is used to manage menopausal symptoms. Dispensing patterns are influenced by evolving guidelines, clinical practice, and public perceptions, which have shifted considerably over the past two decades. This study aims to describe patterns and age‐specific trajectories of MHT dispensing in Sweden in a closed cohort of women aged 45–60 years at baseline, followed from 2006 to 2020. Material and Methods A population‐based closed cohort study linking several Swedish national health registers was performed. A total of 951 455 women aged 45–60 years residing in Sweden were included on January 1, 2006, and followed up until December 31, 2020. MHT dispensing was examined through three approaches: 1) local or no MHT versus systemic MHT, 2) oral versus transdermal estrogen, and 3) based on progestogen type and administration route. Analyses were also stratified by age at baseline (45–49, 50–54, 55–60 years).

Results

Systemic MHT dispensing was 9.6% in 2006 and 3.8% in 2020, while 6.7% and 16.7% used local MHT, respectively. The oldest age group consistently dispensed systemic MHT to a greater extent through the years. Oral estrogen dominated, although relative transdermal estrogen use increased modestly toward the end of follow‐up. Dispensing of systemic MHT was less common among women born outside Europe, while dispensing of transdermal estrogen, compared to oral, was higher among those with higher education and income. Synthetic progestogens remained the most common type of progestogen, whereas dispensing of bioidentical progesterone/dydrogesterone and hormonal intrauterine devices was rare.

Conclusions

In this large, population‐based, closed cohort of women in Sweden, dispensing of systemic MHT declined with increasing age, while local MHT increased. Dispensing patterns, including route of estrogen administration and type of progestogen, varied by age cohort and sociodemographic characteristics. These findings illustrate how MHT dispensing is shaped by aging, cohort effects, evolving clinical practices, and updated guidelines, as well as by social determinants of health. Overall, the results underscore the importance of continued monitoring of MHT dispensing and efforts to ensure that prescribing remains evidence‐based and equitable.

Subjects

MeSH terms (MEDLINE)

Estrogen Replacement TherapyMenopausePractice Patterns, Physicians'Hormone Replacement TherapyHumansFemaleMiddle AgedSwedenRegistriesCohort StudiesProgestinsAdministration, CutaneousEstrogensAge FactorsAdministration, Oral

Author keywords

drug utilization patternshormone replacement therapymenopausal hormone therapymenopausepharmacoepidemiologypopulation‐based register cohort study

Substances

ProgestinsEstrogens

Authors and institutions

  • Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Centre for Pharmacoepidemiology, Division of Clinical Epidemiology (KEP), Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Obstetrics & Gynecology, Uppsala University Hospital, Uppsala, Sweden.
  • Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

ORCID profiles: Rebecca Götze Eriksson, Evangelia Elenis

Funding

  • Svenska sällskapet för medicinsk forskning
  • Vetenskapsrådet
  • Cancerfonden
  • Riktade forsknings- och utvecklingsmedel Region Uppsala
  • Uppsala Region
  • Svenska Läkaresällskapet
  • Regionala Forskningsrådet Uppsala/Örebro

Cite

APA

Götze Eriksson, R., Söderquist, F., Bai, G., Wikman, P., Giunta, D. H., Sundström Poromaa, I., Elenis, E., Hirschberg, A. L., Skalkidou, A., & Iliadis, S. I. (2026). Patterns of menopausal hormone therapy dispensing over 15 years—A Swedish register‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70225

Vancouver

Götze Eriksson R, Söderquist F, Bai G, Wikman P, Giunta DH, Sundström Poromaa I, et al. Patterns of menopausal hormone therapy dispensing over 15 years—A Swedish register‐based cohort study. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70225

BibTeX
@article{GtzeEriksson2026,
  author = {Götze Eriksson, Rebecca and Söderquist, Fanny and Bai, Ge and Wikman, Per and Giunta, Diego Hernan and Sundström Poromaa, Inger and Elenis, Evangelia and Hirschberg, Angelica Lindén and Skalkidou, Alkistis and Iliadis, Stavros I},
  title = {Patterns of menopausal hormone therapy dispensing over 15 years—A Swedish register‐based cohort study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  doi = {10.1111/aogs.70225}
}
Start for free →